西罗莫司片是医保药吗？

Are sirolimus tablets a medically insured drug? It is a medical insurance drug. This product is a prescription drug and a national medical insurance catalog (Category B) drug. For specific reimbursement information, patients can consult the local hospital or medical insurance department. Compared with domestic sirolimus tablets, the sirolimus tablets sold in India are more cost-effective. For detailed drug information, you can consult the medical companion travel service.

Sirolimus is a triene macrolide antibiotic extracted from Streptomyces culture fluid and is a T cell inhibitor. It is suitable for patients undergoing kidney transplantation to prevent organ rejection. It is recommended to be used in combination with cyclosporine and corticosteroids. Sirolimus tablets (rapamin) inhibit the activation and proliferation of T lymphocytes stimulated by antigens and cytokines (interleukins IL-2, IL-4 and IL-15). It also inhibits the production of antibodies.

Patients should note when using rapamycin (): This drug is taken orally, once a day. Patients should start taking it as soon as possible after receiving a kidney transplant. New transplant recipients should take a loading dose for the first time, which is three times their maintenance dose. The recommended loading dose for kidney transplant patients is 6 mg and the maintenance dose is 2 mg/day. Although the loading dose of 15 mg and the maintenance dose of 5 mg/day used in clinical trials are safe and effective, the therapeutic benefits of doses above 2 mg are unclear for kidney transplant patients. This drug should be contraindicated in patients who are allergic to sirolimus, sirolimus derivatives, or any ingredients in the oral solution of this drug, as well as pregnant and lactating women. Since grapefruit juice can slow down the metabolism of the drug regulated by CYP3A4 to varying degrees, patients should not use grapefruit juice to take or dilute the drug when taking rapamycin.

Recommended related hot articles: /newsDetail/83737.html